AT
GILD icon

Arvest Trust’s Gilead Sciences GILD Stock Holding History

Arvest Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$8.1M Sell
118,075
-4,749
-4% -$317K 0.48% 57
2024
Q1 		$9M Sell
122,824
-3,234
-3% -$249K 0.51% 55
2023
Q4 		$10.2M Sell
126,058
-2,961
-2% -$230K 0.62% 51
2023
Q3 		$9.67M Sell
129,019
-810
-0.6% -$62.3K 0.63% 52
2023
Q2 		$9.89M Sell
129,829
-3,875
-3% -$309K 0.59% 52
2023
Q1 		$11.1M Sell
133,704
-6,391
-5% -$529K 0.69% 47
2022
Q4 		$12M Sell
140,095
-14,052
-9% -$1.11M 0.76% 46
2022
Q3 		$9.51M Sell
154,147
-5,141
-3% -$324K 0.65% 49
2022
Q2 		$9.85M Sell
159,288
-1,235
-0.8% -$76.5K 0.64% 49
2022
Q1 		$9.54M Sell
160,523
-3,292
-2% -$210K 0.53% 54
2021
Q4 		$11.9M Buy
+163,815
New +$11.3M 0.63% 50
2014
Q2 		$18.6M Buy
224,080
+703
+0.3% +$54.7K 1.72% 12
2014
Q1 		$17.5M Sell
223,377
-1,779
-0.8% -$140K 1.69% 13
2013
Q4 		$16.9M Sell
225,156
-5,370
-2% -$374K 1.68% 16
2013
Q3 		$14.5M Sell
230,526
-230,447
-50% -$13.8M 1.58% 21
2013
Q2 		$23.6M Buy
+460,973
New +$24M 2.71% 7

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arvest Trust's GILD Position: Q2 2024 in Review

Arvest Trust reduced its Gilead Sciences (GILD) stake by 3.9% in Q2 2024, selling an estimated $317K and leaving 118,075 shares worth $8.1M. The position accounts for 0.48% of the portfolio, ranked #57.

Arvest Trust first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $23.6M in Q2 2013. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Arvest Trust held 118,075 shares of Gilead Sciences worth $8.1M as of Q2 2024.
  • Arvest Trust sold 4,749 Gilead Sciences shares in Q2 2024, an estimated $317K.
  • Gilead Sciences made up 0.48% of Arvest Trust's portfolio in Q2 2024, its #57 holding.
  • Arvest Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • Arvest Trust's Gilead Sciences position peaked at $23.6M in Q2 2013.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.